Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study

@article{Hatano2017PostoperativeEU,
  title={Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study},
  author={K. Hatano and T. Okusa and Yu Ishizuya and Yasutomo Nakai and Masashi Nakayama and K. Kakimoto and K. Nishimura},
  journal={Japanese Journal of Clinical Oncology},
  year={2017},
  volume={47},
  pages={74–79}
}
  • K. Hatano, T. Okusa, +4 authors K. Nishimura
  • Published 2017
  • Medicine
  • Japanese Journal of Clinical Oncology
  • Objective To identify predictors for biochemical recurrence among patients with positive surgical margins (RM1) after radical prostatectomy and to examine the effect of ultrasensitive prostate-specific antigen measured early after prostatectomy on biochemical recurrence. Methods We identified 705 patients with prostate cancer who were treated with radical prostatectomy without preoperative hormonal therapy at our institution between 2000 and 2014. The patients with RM1 who had a postoperative… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 34 REFERENCES
    Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.
    • 20
    • Highly Influential
    • Open Access
    Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.
    • 171
    • Open Access
    The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
    • 14
    • Open Access